Top Markets
Coin of the day
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
Classement en actions #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
Prix de l'action
$2.65
Dernière synchronisation: 2024-04-03
Capitalisation boursière
$115.71M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Kinnate Biopharma Inc. (KNTE)

Catégorie

Historique des divisions d’actions pour Kinnate Biopharma Inc. (KNTE)
L’action Kinnate Biopharma Inc. (symbole : KNTE) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 23, 2026.
Une action KNTE achetée avant le Aug 23, 2026 équivaudrait aujourd’hui à 0 actions KNTE.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH